CAS No. 113403-19-3

bapineuzumab

5-CHLORO-1-(2-CHLOROPHENYL)-1-OXOPENTANE

(1S,2R)-1,2-Dimethyl-3-methylenecyclopropane

Octanoic acid, 2-methyl-, sulfophenyl ester, sodium salt

1H-Pyrrole-3-carbonitrile, 5-amino-1-(2,3-dihydro-1H-inden-1-yl)-

2-METHYL-N-[4-METHYL-3-(4-PIPERIDINYL)PHENYL]PROPANAMIDE

486451-46-1

1H-Pyrrole-3-carbonitrile, 5-amino-1-[(4-fluorophenyl)phenylmethyl]-

2-Thiazolidinethione, 4-(1-methylethyl)-3-(1-oxopropyl)-, (4R)-

17-bromo-9beta,11beta-epoxy-21-hydroxy-16alpha-methylpregna-1,4-diene-3,20-dione 21-acetate

CHEMBRDG-BB 5522694

Hexanedioic acid, compd. with 1-propanamine

5-CHLORO-1-(2-FLUOROPHENYL)-1-OXOPENTANE

487058-75-3

2,6-Pyridinedicarboxamide, N,N'-bis(2-pyridinylmethyl)-, hydrate (2:1)

1,3,6,8-Tetraoxaspiro[4.4]nonane-2,7-dione

Methyl, 1-aziridinylphenyl-

N-[(Benzyloxy)carbonyl]glycine 2,4,5-trichlorophenyl ester

3-Tetradecanone, 4-ethylidene-2-hydroxy-, (4E)-

Benzenesulfinamide, 4-[2-(ethylthio)ethoxy]-N-6-phthalazinyl-

487024-41-9

ochratoxin C

Scandium, hydroxymethyl-

2H-Pyran-3-carboxylic acid, tetrahydro-4-oxo-2,6-diphenyl-, methylester, (2R,3S,6S)-rel-

Benzenesulfonamide, 2,5-dichloro-N-[(1R)-1-phenylethyl]-

1H-Pyrrolo[2,3-b]pyridine-3-carbonitrile,4,6-dimethyl-1-(2-thienylmethyl)-

648893-86-1

5-CHLORO-1-(3-FLUOROPHENYL)-1-OXOPENTANE

CARBAMIC ACID,BUTYL[(2R,4S)-1-(4-ETHYLBENZOYL)-6-FLUORO-1,2,3,4-TETRAHYDRO-2-METHYL-4-QUINOLINYL]-,1,1-DIMETHYLETHYL ESTER,REL-

4-Isopropylidene-2,2,3,3-tetramethylcyclobutanone

(20R)-3β,29-Dihydroxyolean-12-en-28-oic acid

1-PIPERIDINEETHANAMINE,A-METHYL-,(AR)-

Acetamide, N,N'-[1,4-phenylenebis(carbonyl-4,1-phenylene)]bis-

486420-64-8

Isooctanoyl-L-Glutamic-α, γ-Dibutylamide

5-CHLORO-1-OXO-1-(3-TRIFLUOROMETHYLPHENYL)PENTANE

(Z)-undec-8-ene-2,5-dione

9H-CYCLOPENTA[B]QUINOLIN-9-IMINE,4-ETHYL-1,2,3,4-TETRAHYDRO-

1-(2-BROMOPHENYL)-5-CHLORO-1-OXOPENTANE

2-Propenoic acid,3-[1-[bis(4-fluorophenyl)methyl]-3-cyano-4,6-dimethyl-1H-pyrrolo[2,3-b]pyridin-2-yl]-, ethyl ester, (2E)-

648893-82-7